|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 47/50 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2644204 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13158391.6 |
| Europos patento paraiškos padavimo data | 2009-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 37410 P | 2008-03-18 | US |
| (72) |
Berry, Leanne, US
Phillips, Gail, Lewis, US
Sliwkowski Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab |
| Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab |